Published in Hypertens Res on November 01, 2001
Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation | NCT04017806
Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20
Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol (2008) 3.42
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.74
The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med (2008) 1.65
The relationship between serum uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant (2010) 1.60
Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids (2008) 1.59
A prospective controlled study of kidney donors: baseline and 6-month follow-up. Am J Kidney Dis (2013) 1.55
Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant (2008) 1.55
A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis (2015) 1.48
Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) (2012) 1.38
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care (2011) 1.23
Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens (2009) 1.22
Uric acid as a target of therapy in CKD. Am J Kidney Dis (2012) 1.22
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep (2013) 1.20
Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout. Clin Exp Nephrol (2014) 1.09
Fructose and uric acid in diabetic nephropathy. Diabetologia (2015) 0.99
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria. Biopharm Drug Dispos (2014) 0.99
Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther (2009) 0.98
Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant (2011) 0.97
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol (2015) 0.94
Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4. PLoS One (2014) 0.91
Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. Heart Vessels (2013) 0.91
Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.90
Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy. Adv Ther (2015) 0.90
Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol (2010) 0.89
Uric Acid as a Marker of Kidney Disease: Review of the Current Literature. Dis Markers (2015) 0.87
Uric acid levels predict future blood pressure and new onset hypertension in the general Japanese population. J Hum Hypertens (2014) 0.86
Serum uric acid and the incidence of CKD and hypertension. Clin Exp Nephrol (2015) 0.84
Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia. Hypertens Res (2016) 0.83
Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease. Nephrol Dial Transplant (2015) 0.83
Serum uric acid and subsequent cognitive performance in patients with pre-existing cardiovascular disease. PLoS One (2015) 0.83
Management of Gout and Hyperuricemia in CKD. Am J Kidney Dis (2017) 0.82
Serum uric acid levels and long-term outcomes in chronic kidney disease. Heart Vessels (2013) 0.82
Hypertension and chronic kidney disease: controversies in pathogenesis and treatment. Minerva Urol Nefrol (2013) 0.81
Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am (2014) 0.81
Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. J Clin Diagn Res (2014) 0.81
Distribution of and factors contributing to chronic kidney disease in a middle-aged working population. Environ Health Prev Med (2013) 0.80
Association of renal manifestations with serum uric acid in Korean adults with normal uric acid levels. J Korean Med Sci (2010) 0.80
Clinical epidemiology of reduced kidney function among elderly male fishing and agricultural population in Taipei, Taiwan. Biomed Res Int (2013) 0.79
Serum uric acid and cardiovascular disease. Maedica (Buchar) (2010) 0.79
Serum urate levels and consumption of common beverages and alcohol among Chinese in Singapore. Arthritis Care Res (Hoboken) (2013) 0.79
The relationship between serum levels of uric acid and prognosis of infection in critically ill patients. World J Emerg Med (2012) 0.79
The association between serum uric acid and renal damage in a community-based population: the Takahata study. Clin Exp Nephrol (2012) 0.79
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 0.79
Association of a polymorphism in a gene encoding a urate transporter with CKD progression. Clin J Am Soc Nephrol (2014) 0.78
Correlation between renal function and common risk factors for chronic kidney disease in a healthy middle-aged population: a prospective observational 2-year study. PLoS One (2014) 0.78
Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol (2015) 0.78
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review. Adv Ther (2016) 0.77
Time to target uric acid to retard CKD progression. Clin Exp Nephrol (2016) 0.77
Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis. J Biomed Biotechnol (2010) 0.76
Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromsø study. Nutr J (2015) 0.76
Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76
Common variant of ALPK1 is not associated with gout: a replication study. Hum Cell (2014) 0.76
Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study. Clin Rheumatol (2016) 0.76
Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis. PLoS One (2015) 0.75
Elevated Blood Pressure and Serum γ -Glutamyltransferase as Significant Characteristics of Smokers With Chronic Kidney Disease. Nephrourol Mon (2014) 0.75
The impact of serum uric acid on the natural history of glomerular filtration rate: a retrospective study in the general population. PeerJ (2016) 0.75
Urate oxidase knockdown decreases oxidative stress in a murine hepatic cell line. Oxid Med Cell Longev (2010) 0.75
Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study. BMC Nephrol (2015) 0.75
Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012. Clin Exp Nephrol (2013) 0.75
Association between serum uric acid, urinary albumin excretion, and glycated hemoglobin in Type 2 diabetic patient. Niger Med J (2016) 0.75
Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension. Cardiol Res (2016) 0.75
Serum Uric Acid Level in Relation to Severity of the Disease and Mortality of Critically Ill Patients. J Lab Physicians (2017) 0.75
Hyperuricemia: An Early Marker for Severity of Illness in Sepsis. Int J Nephrol (2015) 0.75
Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension. Cardiol Res (2016) 0.75
ARISTOLOCHIA BRACTEOLATE RETZ. ATTENUATES HYPERURICEMIA IN A METABOLIC ARTHRITIS RAT MODEL. Afr J Tradit Complement Altern Med (2017) 0.75
Demographic study of first-ever stroke and acute myocardial infarction in Okinawa, Japan. Intern Med (1998) 1.79
Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem (2001) 1.61
Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int (1996) 1.60
Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension (2000) 1.54
Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood (2000) 1.54
Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension. Am J Hypertens (1998) 1.47
Effects of propranolol on cardiovascular and neurohumoral actions of alcohol in hypertensive patients. Blood Press (1999) 1.38
Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry (1999) 1.30
Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J (1998) 1.26
Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int (1997) 1.21
Blunted parasympathetic modulation in salt-sensitive patients with essential hypertension: evaluation by power-spectral analysis of heart-rate variability. J Hypertens (1997) 1.18
Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat. Hypertension (1989) 1.17
Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant (1999) 1.14
Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun (2001) 1.12
Seasonal variations in office, home and 24 h ambulatory blood pressure in patients with essential hypertension. J Hypertens (1996) 1.09
Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol (2000) 1.06
Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension (1998) 1.06
Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur J Pharmacol (1999) 1.01
Catabolism of globin-haptoglobin in liver cells after intravenous administration of hemoglobin-haptoglobin to rats. J Biol Chem (1981) 0.98
MEFV mutation analysis of familial Mediterranean fever in Japan. Clin Exp Rheumatol (2008) 0.97
Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan. Jpn Circ J (1999) 0.96
Treatment of severe hypothyroidism reduced serum creatinine levels in two chronic renal failure patients. Nephron (2001) 0.95
An epidemiologic analysis of parathyroidectomy in chronic dialysis patients. The Okinawa Dialysis Study Group. Nihon Jinzo Gakkai Shi (1996) 0.93
Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci (Lond) (1999) 0.93
Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart (1998) 0.93
Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int Suppl (1997) 0.92
Clinical alterations in normotensive offspring with parental hypertension. J Hypertens Suppl (1988) 0.92
Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction. Int J Cardiol (1998) 0.91
A case report of caudal regression syndrome associated with an intraspinal arachnoid cyst. Pediatr Neurosurg (1999) 0.90
Successful management of ruptured duodenal varices by means of endoscopic variceal ligation: report of a case. Gastrointest Endosc (1999) 0.88
Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1beta and tumor necrosis factor-alpha. Endocrinology (1998) 0.88
Ageing suppresses endothelium-dependent relaxation and generates contraction mediated by the muscarinic receptors in vascular smooth muscle of normotensive Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens Suppl (1988) 0.87
Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis (2001) 0.87
Family history of hypertension and blood pressure in a screened cohort. Hypertens Res (2001) 0.87
Exacerbation of renal failure due to hypothyroidism in a patient with ischemic nephropathy. Nephron (2000) 0.87
Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Br J Clin Pharmacol (2000) 0.86
Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger. Am J Kidney Dis (2001) 0.85
Effect of the Hanshin-Awaji earthquake on home blood pressure in patients with essential hypertension. Am J Hypertens (1997) 0.84
Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. J Thorac Cardiovasc Surg (1998) 0.84
Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol (2000) 0.83
Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res (2000) 0.83
Autonomic function in hypertensive patients with neurovascular compression of the ventrolateral medulla oblongata. J Hypertens (1999) 0.83
Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int Suppl (1996) 0.82
Plasma levels of adrenomedullin in patients with acute myocardial infarction. Clin Sci (Lond) (1998) 0.81
Brain angiotensin and circulatory control. Clin Exp Pharmacol Physiol (1996) 0.80
Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension (1997) 0.80
Purification and characterization of membrane-bound hydrogenase from Hydrogenobacter thermophilus strain TK-6, an obligately autotrophic, thermophilic, hydrogen-oxidizing bacterium. Biosci Biotechnol Biochem (2000) 0.80
Acute and chronic effects of a hypocaloric diet on 24-hour blood pressure, heart rate and heart-rate variability in mildly-to-moderately obese patients with essential hypertension. Clin Exp Hypertens (1999) 0.80
Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis. Heart (1997) 0.80
The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. Am J Hypertens (1997) 0.80
Guidelines for hypertension in the elderly--1999 revised version. Ministry of Health and Welfare of Japan. Hypertens Res (1999) 0.79
Structure of the human transcription factor TFIIF revealed by limited proteolysis with trypsin. FEBS Lett (1998) 0.79
Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats. J Hypertens (1995) 0.79
Ticlopidine and thrombocytopenia. N Engl J Med (1990) 0.79
Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol (1998) 0.79
Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan. Jpn Circ J (1998) 0.79
Effects of meal ingestion and active standing on blood pressure in patients > or = 60 years of age. Am J Cardiol (1998) 0.79
Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. J Hypertens (2001) 0.79
High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J (2001) 0.78
Effect of exercise on plasma adrenomedullin and natriuretic peptide levels in myocardial infarction. Clin Exp Pharmacol Physiol (1997) 0.78
Seasonal blood pressure and body weight variation in patients on chronic hemodialysis. Am J Nephrol (1999) 0.78
Pressor responses to intracisternal administration of hypertonic NaCl in conscious normotensive and spontaneously hypertensive rats. Arch Int Pharmacodyn Ther (1989) 0.78
Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension (1997) 0.78
Short-term effects of angiotensin II blockade on renal blood flow and sympathetic activity in awake rats. Hypertension (1994) 0.78
Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients. Clin Nephrol (2002) 0.78
Responses of natriuretic peptides to acute and chronic salt loading in normotensive and hypertensive subjects. Hypertens Res (1998) 0.78
Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus. Diabet Med (2005) 0.78
[A female case of Fournier's gangrene in a patient with lupus nephritis]. Nihon Jinzo Gakkai Shi (1998) 0.78
Effects of interferon on C1300 mouse neuroblastoma. Cancer Treat Rep (1982) 0.78
Plasma dopamine-beta-hydroxylase activity in normal young men: its responsiveness to manipulation of sodium balance and upright posture. Jpn Circ J (1977) 0.78
Lack of increase in sodium concentration of cerebrospinal fluid in DOCA-salt hypertensive rats. Am J Hypertens (1988) 0.77
Successful management of critical limb ischemia with intravenous sodium thiosulfate in a chronic hemodialysis patient. Clin Nephrol (2006) 0.77
Glucose tolerance and insulin secretion in conscious and unrestrained normotensive and spontaneously hypertensive rats. Metabolism (1989) 0.77
Modulation of baroreflex function by angiotensin II endogenous to the caudal ventrolateral medulla. Brain Res (1995) 0.77
Carpal tunnel syndrome as an initial manifestation in a case of transthyretin-related familial amyloid polyneuropathy with a novel A120T mutation. Clin Neurol Neurosurg (2011) 0.77
Plasma levels of carcinoembryonic antigen in patients with ataxia-telangiectasia. J Pediatr (1978) 0.77
Amlodipine, a long-acting calcium channel blocker, attenuates morning blood pressure rise in hypertensive patients. Clin Exp Pharmacol Physiol (1999) 0.77
Lack of interaction between a hypertonic NaCl stimulus and the brain renin-angiotensin system. Am J Physiol (1983) 0.77
Multiple risk factor clustering of hypertension in a screened cohort. J Hypertens (2000) 0.77
Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects. Clin Exp Hypertens (1997) 0.77
Calcium supplementation in patients with essential hypertension: assessment by office, home and ambulatory blood pressure. J Hypertens (1998) 0.77
Contribution of alpha 2-adrenoceptors in caudal ventrolateral medulla to cardiovascular regulation in rat. Am J Physiol (1998) 0.76
Different effects of alcohol and salt on 24-hour blood pressure and heart rate in hypertensive patients. Hypertens Res (1996) 0.76
Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats. Clin Exp Hypertens A (1988) 0.76
Effects of alcohol restriction on 24-hour ambulatory blood pressure in Japanese men with hypertension. Am J Med (1998) 0.76
Carbamazepine-induced hyponatremia in a patient with partial central diabetes insipidus. Nephron (1993) 0.76
Pathophysiology in malignant hypertension: with special reference to the renin-angiotensin system. Clin Cardiol (1987) 0.76
Plasma levels of natriuretic peptides and adrenomedullin in elderly hypertensive patients: relationships to 24 h blood pressure. J Hypertens (1998) 0.76
Role of ouabain-like compound in the rostral ventrolateral medulla in rats. J Clin Invest (1997) 0.75
Central and peripheral mechanisms of the enhanced hypertension following long-term salt loading in spontaneously hypertensive rats. Jpn Circ J (1988) 0.75